Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval
Vanda Pharmaceuticals(US:VNDA) Barrons·2025-12-31 15:57The FDA approved Vanda's drug Nereus to prevent motion-induced vomiting, opening a potential path into treating nausea linked to GLP-1 weight-loss drugs. ...